Results 111 to 120 of about 38,272 (220)

What Are the Best Predictors of STEM Competences in PISA 2018? An Analysis of the Spanish Context Using Data Mining

School Science and Mathematics, EarlyView.
ABSTRACT The importance of Science, Technology, Engineering, and Mathematics (STEM) subjects for the present and future society is clear. With assessments such as the Programme for International Student Assessment (PISA), the possibility of an analysis on student‐related variables predicting results in STEM areas opens. The aim was to identify the PISA
Pedro Gil‐Madrona, Ashly Mercedes Guerrero‐Muguerza, Álvaro Infantes‐Paniagua, María Martínez‐López   +3 more
wiley   +1 more source

Long‐term forecasting of blood donations using time series of donation activity: Findings from seven blood establishments

Vox Sanguinis, EarlyView.
Abstract Background and Objectives To meet the long‐term demand for blood products while preserving donor health in the long run, blood establishments must recruit a sufficient number of new donors annually. To determine what will suffice, it is essential to be able to forecast future blood donation volumes as a function of new donors using estimates ...
Timo Asikainen, Tinus Brits, Ronél Swanevelder, Jose Antonio García Erce, Lucile Malard, Iris Garcia‐Martínez, Marijke Welvaert, Surendra Karki, Tea Lallukka, Mart Pothast, Mikko Arvas   +10 more
wiley   +1 more source

Acute systemic and energy metabolism responses to velocity‐based resistance training following an oral glucose load in individuals with excess body weight

Experimental Physiology, EarlyView.
Abstract We investigated the acute metabolic effects of two velocity‐based resistance training (RT) protocols, differing in intra‐set velocity loss (VL) thresholds, on postprandial substrate oxidation and glycaemic responses following a 75 g oral glucose tolerance test in individuals with excess body weight.
Hugo Alejandro Carrillo‐Arango, Miguel Alejandro Atencio‐Osorio, Leidy Tatiana Ordoñez‐Mora, Baisuli Benitez‐Gómez, Robinson Ramírez‐Vélez, Mikel Izquierdo   +5 more
wiley   +1 more source

Topic Modeling of Fatty Acid Studies: Evaluating Environmental Changes in Freshwater Ecosystems

International Review of Hydrobiology, Volume 111, Issue 1, June 2026.
ABSTRACT Fatty acids (FAs) are biochemical molecules with vital structural and metabolic functions in all living organisms. Over the last decades, FA analysis in ecological studies has garnered significant attention due to its diverse applicability, such as taxonomic support for species identification, investigations on trophic interactions, and ...
A. C. Campos, B. Gücker, I. G. Boëchat
wiley   +1 more source

Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series. [PDF]

Vaccines (Basel)
Esparragosa Vázquez I, López-Díaz de Cerio A, Inoges S, Aristu J, Domínguez P, García-Eulate R, Calvo-Imirizaldu M, Arbizu J, Rodríguez-Ruiz ME, Irimia P, Alonso MM, Prósper F, Díez-Valle R, Gállego Pérez-Larraya J.   +13 more
europepmc   +1 more source

Effects of Diactive‐1–Supported Progressive Resistance Training on Body Composition in Youth With Type 1 Diabetes

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 2, April 2026.
ABSTRACT Background Compared to their healthy peers, children and adolescents with type 1 diabetes are at an increased risk of adverse changes in body composition, including increased fat mass along with reductions in lean and bone mass. Although exercise has shown promise in improving body mass index in this population, the individual effects of ...
Jacinto Muñoz‐Pardeza, José Francisco López‐Gil, Ignacio Hormazábal‐Aguayo, Mikel Izquierdo, Cesar Agostinis‐Sobrinho, Yasmin Ezzatvar, Antonio García‐Hermoso   +6 more
wiley   +1 more source

Correction: SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2025). [PDF]

Clin Transl Oncol
Aguilera MJS, Gaspá FL, González-Flores E, Mirón MLL, Mozo JLM, Del Carmen Riesco Martínez M, Vidal-Tocino R, Orduña VA, Martínez EA, García RV.   +9 more
europepmc   +1 more source

Navarra

, 1902
Indica coordenadas referidas al meridiano de Madrid: E 1º00'--E 3º00' /N 43º20'--N 41º52'. Figuran ademas latitud y longitud de la capital de provincia y coordenadas horarias. Indica relieve representado por líneas perpendiculares normales. Indica el límite de los partidos judiciales. Incluye leyenda de símbolos utilizados.
openaire   +1 more source

APECx—Anaesthesia, Perfusion and Surgical Practices in Cardiac Surgery: Main Study Protocol of a Modular Multiphase Prospective International Multicentre Observational Study

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 4, April 2026.
ABSTRACT The perioperative management in adult cardiac surgery patients remains highly variable across centres and regions. The APECx study (Anaesthesia, Perfusion and surgical practicEs in Cardiac surgery) aims to describe the incidence of key clinical patient outcomes, map global variation in anaesthesia, perfusion and surgical practices in cardiac ...
Jord C. Seegers, Nimrat Grewal, Relin van Vliet, Tim Berger, Bhiraj Bhatia, Crispiana Cozowicz, Martin Czerny, Jacopo D’Andria Ursoleo, Alessandro Della Corte, Stefan Dodic, Jonathon P. Fanning, Lukas Gasteiger, Simran Grewal, Lars Grønlykke, Ragnar Huhn, Mohammad Idhrees, Theis Skovsgaard Itenov, Arminder S. Jassar, Jae‐Woo Ju, Dharshi Karalapillai, Gudrun Kunst, Lukas Lannemyr, D‐Yin Lin, Carlo Mariani, Andreas Martinsson, Erin McCabe, Benjamin Milne, Fabrizio Monaco, Peter Hasse Møller‐Sørensen, Matthias Neuner, Davide Pacini, Luke A. Perry, Jaishankar Raman, A. Floriaan Schmidt, Florian Schoenhoff, Reny Segal, Ary Serpa Neto, Douglas C. Shook, Carolin Torregroza, Marc Vives, Vasileios Zochios, David M. P. van Meenen, Anne M. Beukers   +42 more
wiley   +1 more source

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.
In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.
Marco Sanduzzi‐Zamparelli, Ana Matilla, José Luis Lledo, Sergio Muñoz‐Martínez, María Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Mínguez, Neus Llarch, Laura Márquez, Antonio Guerrero, Gemma Iserte, Andrés Castaño‐García, Laura Carrión, Marta Fortuny, Jordi Rimola, Ángeles García‐Criado, Gema Domenech, Ferran Torres, José Rios‐Guillermo, Loreto Boix, Esther Samper, Àngels Kateb, Jordi Bruix, Maria Reig   +24 more
wiley   +1 more source